CMP* (Rs) 198 Upside/ (Downside) (%) 12. Market Cap. (Rs bn) 61 Free Float (%) 84 Shares O/S (mn) 308

Similar documents
CMP* (Rs) 189 Upside/ (Downside) (%) (1) Bloomberg Ticker PNB IN Market Cap. (Rs bn) 402 Free Float (%) 38 Shares O/S (mn) 2,128

CMP (Rs) 166 Upside/ (Downside) (%) (1) Bloomberg Ticker Market Cap. (Rs bn) 125 Free Float (%) 37 Shares O/S (mn) 726

BUY. DCB Bank. Improving Capital Consumption to Aid Returns; Maintain BUY. Target Price: Rs202. Institutional Equity Research

CMP* (Rs) 242 Upside/ (Downside) (%) 2. Market Cap. (Rs bn) 157 Free Float (%) 65.6 Shares O/S (mn) 630

CMP* (Rs) 145 Upside/ (Downside) (%) 32 Bloomberg Ticker BOB IN Market Cap. (Rs bn) 384 Free Float (%) 36 Shares O/S (mn) 2,646

CMP* (Rs) 208 Upside/ (Downside) (%) 18. Market Cap. (Rs bn) Free Float (%) 65.6 Shares O/S (mn) 630

CMP (Rs) 775 Upside/ (Downside) (%) (1.4) Market Cap. (Rs bn) 11.4 Free Float (%) 35.0 Shares O/S (mn) 14.7

CMP* (Rs) 166 Upside/ (Downside) (%) 28 Bloomberg Ticker. NTPC IN Market Cap. (Rs bn) 1,361 Free Float (%) 37.7 Shares O/S (mn) 8,245

CMP* (Rs) 336 Upside/ (Downside) (%) 21 Bloomberg Ticker. MOIL IN Market Cap. (Rs bn) 45 Free Float (%) 24 Shares O/S (mn) 133

CMP* (Rs) 161 Upside/ (Downside) (%) 19 Bloomberg Ticker. NTPC IN Market Cap. (Rs bn) 1,329 Free Float (%) 30.3 Shares O/S (mn) 8,245

CMP* (Rs) 840 Upside/ (Downside) (%) (2.4) Bloomberg Ticker Market Cap. (Rs bn) 379 Free Float (%) 53 Shares O/S (mn) 451.6

CMP* (Rs) 172 Upside/ (Downside) (%) 11.6 Bloomberg Ticker. NTPC IN Market Cap. (Rs bn) 1,414 Free Float (%) 30.3 Shares O/S (mn) 8,245

CMP* (Rs) 263 Upside/ (Downside) (%) 7.3. Market Cap. (Rs bn) 635 Free Float (%) 59 Shares O/S (mn) 2,417

CMP* (Rs) 360 Upside/ (Downside) (%) 25. Market Cap. (Rs bn) 38 Free Float (%) 76 Shares O/S (mn) 104.5

CMP* (Rs) 1,458 Upside/ (Downside) (%) 10 Bloomberg Ticker. ABB IN Market Cap. (Rs bn) 309 Free Float (%) 25 Shares O/S (mn) 212

CMP* (Rs) 203 Upside/ (Downside) (%) 23. Market Cap. (Rs bn) 116 Free Float (%) 61 Shares O/S (mn) 572

BUY NCC. An Ordinary Quarterly Performance; Maintain BUY. Target Price: Rs98. Institutional Equity Research. 4QFY17 Result Update May 24, 2017

Nestlé India Outlook Hazy; Valuations Prohibitive

BUY CDSL. Strong Operating Performance; Maintain BUY. Target Price: Rs435. Institutional Equity Research. 2QFY18 Result Update October 31, 2017

CMP* (Rs) 346 Upside/ (Downside) (%) 17. Market Cap. (Rs bn) 23 Free Float (%) 42.0 Shares O/S (mn) 67

HOLD. Nestle. Good Performance Irrespective of GST Pangs. Target Price: Rs6,624. Institutional Equity Research. 2QCY17 Result Update July 27,2017

CMP* (Rs) 1,033 Upside/ (Downside) (%) (0.3) Bloomberg Ticker Market Cap. (Rs bn) 467 Free Float (%) 53 Shares O/S (mn) 452

BUY NTPC. Higher Regulated Equity to Aid Profitability; Maintain BUY. Target Price: Rs192. Institutional Equity Research

Titan Company BUY. Back to Value Zone Validate Rating Upgrade. Institutional Equity Research. November 05, Target Price Rs428.

CMP* (Rs) 417 Upside/ (Downside) (%) 46 Bloomberg Ticker. SUNP IN Market Cap. (Rs bn) 1,001 Free Float (%) 46 Shares O/S (mn) 2399

CMP* (Rs) 205 Upside/ (Downside) (%) 12 Bloomberg Ticker. NACO IN Market Cap. (Rs bn) 29 Free Float (%) 27 Shares O/S (mn) 143

CMP* (Rs) 1,464 Upside/ (Downside) (%) 10. Market Cap. (Rs bn) 91 Free Float (%) 55 Shares O/S (mn) 62

HOLD ACC. Strong Performance on Better Volume and Firm Realizations. Target Price: Rs1,640. Institutional Equity Research

CMP (Rs) 326 Upside/ (Downside) (%) 24. Market Cap. (Rs bn) 21.7 Free Float (%) 42.0 Shares O/S (mn) 67

CMP (Rs) 249 Upside/ (Downside) (%) Market Cap. (Rs bn) 25.5 Free Float (%) 29.7 Shares O/S (mn) 102.3

CMP* (Rs) 237 Upside/ (Downside) (%) 29 Bloomberg Ticker. APTY IN Market Cap. (Rs bn) 136 Free Float (%) 55.9 Shares O/S (mn) 509

CMP* (Rs) 289 Upside/ (Downside) (%) 18. Market Cap. (Rs bn) 30 Free Float (%) 69 Shares O/S (mn) 105

KNR Constructions Robust Performance on Execution Ramp-up

CMP (Rs) 702 Upside/ (Downside) (%) 42 Bloomberg Ticker. JKCE IN Market Cap. (Rs bn) 54 Free Float (%) 42 Shares O/S (mn) 77.3

Sonata Software HOLD. Unimpressive Show; IITS Revenue Disappoints. Institutional Equity Research. February 06, Target Price Rs190.

CMP (Rs) 133 Upside/ (Downside) (%) 35 Bloomberg Ticker. ICEM IN Market Cap. (Rs bn) 41 Free Float (%) 71.6 Shares O/S (mn) 308.1

CMP* (Rs) 1,424 Upside/ (Downside) (%) 19 Bloomberg Ticker Market Cap. (Rs bn) 268 Free Float (%) 46 Shares O/S (mn) 188

Federal Bank BUY. Performance Highlights. Target Price. 1QFY2018 Result Update Banking. Stock Info Sector

Aurobindo Pharma. Institutional Equity Research. Sector - Pharmaceuticals. RSec TradEdge India. March 02, 2017

HDFC Bank BUY. Performance Highlights. CMP `2,145 Target Price `2,500. Q3FY2019 Result Update Banking. 3-year price chart. Key financials (Standalone)

Punjab National Bank

Equitas Holdings. Rating: Target price: ABV: Target CMP. Rating. Rs Rs. 226 BUY

South Indian Bank. Institutional Equities. 4QFY18 Result Update. Asset Quality Pain To Ease Hereafter BUY. 15 May 2018

Financial summary. Year

Bank of Baroda (BOB) Banking. BUY Rating as per Large Cap 12 month investment period RETAIL EQUITY RESEARCH

BUY. State Bank of India (SBI) Banking RETAIL EQUITY RESEARCH. GEOJIT BNP PARIBAS Research. CMP Rs259 TARGET Rs284 RETURN 10% 22 nd August 2016

ICICI Bank BUY. Performance Highlights. CMP Target Price `343 `460. Q3FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials

ICICI Bank BUY. Performance Highlights. CMP Target Price `328 `416. 3QFY2018 Result Update Banking. 3-year price chart. Key financials (Standalone)

Axis Bank Ltd. For private circulation only. Volume No.. III Issue No October 08, 2018

Buy Rating as per Mid Cap 12months investment period

HDFC Bank BUY. Operating performance strong; improved NIM. CMP `2,268 Target Price `2,500. Q4FY2019 Result Update Banking. 3-year price chart

RBL Bank Ltd. Banking. ACCUMULATE Rating as per Mid Cap 12 months investment period RETAIL EQUITY RESEARCH

ICICI Bank Banking BUY RETAIL EQUITY RESEARCH

Jubilant FoodWorks. Institutional Equity Research. Sector - FMCG. RSec TradEdge India. January 17, 2017

Punjab National Bank ACCUMULATE. Performance Highlights. CMP `1,115 Target Price `1,259. 3QFY2011 Result Update Banking.

LIC Housing Finance BUY. Performance Highlights. CMP Target Price `532 `630. 3QFY2017 Result Update HFC. 3-Year Daily Price Chart

ICICI Bank BUY. Performance Highlights. CMP Target Price `307 `411. 1QFY2019 Result Update Banking. 3-year price chart. Key financials (Standalone)

Bajaj Finance Limited (BFL) NBFC. BUY Rating as per Large Cap 12 months investment period RETAIL EQUITY RESEARCH

HDFC Bank BUY. Performance Highlights. CMP `1,965 Target Price `2,350. Q2FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials

HDFC Bank (HDFCB IN) Continue to perform strong

HDFC Bank Banking BUY RETAIL EQUITY RESEARCH

DCB Bank Ltd. 1 P a g e

State Bank of India (SBI) Banking. BUY Rating as per Large Cap 12 month investment period RETAIL EQUITY RESEARCH

Punjab National Bank

HDFC Bank ACCUMULATE. Performance Highlights. CMP `2,348 Target Price `2,671. 4QFY2011 Result Update Banking. Key financials

Reduce. Punjab National Bank Banking RETAIL EQUITY RESEARCH. Not out of the woods. GEOJIT BNP PARIBAS Research. 10 th August 2016 Q1FY17 RESULT UPDATE

BUY. Weak P&L performance, good b/s show POWER FINANCE CORP. Target Price: Rs 135. Financial summary (Standalone) Y/E March FY17 FY18E FY19E FY20E

HDFC Bank. In line results; loan growth holding nicely. Source: Company Data; PL Research

Federal Bank BUY RETAIL EQUITY RESEARCH

Dewan Housing Finance

Manappuram Finance (MGFL IN) Healthy operating performance

LIC Housing Finance. Stable performance. Source: Company Data; PL Research

Punjab National Bank

State Bank of India (SBI) Banking BUY RETAIL EQUITY RESEARCH

Repco Home Finance REPCO IN

BUY. ICICI Bank RETAIL EQUITY RESEARCH. Banking. ddd******* GEOJIT Research. Strong traction in retail segment continues

BUY Rating as per Largecap 12months investment period

HDFC Bank Banking. BUY Rating as per Large Ccap 12 month investment period RETAIL EQUITY RESEARCH

Union Bank of India NEUTRAL. Performance Highlights CMP. `393 Target Price - 2QFY2011 Result Update Banking. Investment Period -

HDFC Bank. BUY CMP (Rs.) 1,807 Target (Rs.) 2,000 Potential Upside 11%

HFC NEUTRAL. Performance Highlights CMP. `678 Target Price - 1QFY2013 Result Update HFC. Investment Period - Key financials

ICICI Bank (ICICIBC IN) Strong improvement in asset quality

ICICI BANK Ltd. BUY CMP (Rs.) 334 Target (Rs.) 382 Potential Upside 15% Tide set to turn favourably... For private circulation only

Key estimate revision. Financial summary. Year

Karur Vysya Bank (KVB) KVB IN; KVB.BO

DCB Bank. Strong performance, valuation comforting

BUY. State Bank of India (SBI) Banking RETAIL EQUITY RESEARCH. Outlook getting better. CMP Rs278 TARGET Rs310 RETURN 12% 17 th November 2016

Manappuram Finance (MGFL IN) Growth picks up in gold loan; Microfinance drive profitability

93,707 77,814 90, NIM

RBL Bank BUY. CMP Target Price `573 `690. Quick take BANK. January 7, year price chart

State Bank of India (SBI)

ICICI Bank. Source: Company Data; PL Research

BUY RETAIL EQUITY RESEARCH. HDFC Ltd. NBFC. Better placed among housing finance companies (HFCs) GEOJIT BNP PARIBAS Research

Axis Bank Banking. HOLD Rating as per Large Cap 12 months investment period RETAIL EQUITY RESEARCH

ICICI Bank BUY. Performance Highlights. CMP Target Price `279 `348. 2QFY2016 Result Update Banking. 3-year price chart. Key financials (Standalone)

PTC India Financial Services

Punjab National Bank

Simplex Infrastructures

Axis Bank BUY. CMP Target Price `620 `750. Update Bank. Earnings to normalize with stabilizing credit costs. 3-year price chart.

Karnataka Bank. Institutional Equities. 4QFY18 Result Update. Plucky Bank And Low Hanging Fruit BUY. 17 May Reuters: KBNK.NS; Bloomberg: KBL IN

Transcription:

1QFY18 Result Update July 18, 217 Upside/ (Downside) 12 Market Cap. (Rs bn) 61 Free Float 84 Shares O/S (mn) 38 Healthy Core Operating Performance on Key Metrics; Maintain has posted a higher-than-estimated net earnings in 1QFY18 on the back of 19bps QoQ rise in NIMs to an all-time high of 4.23%, higher treasury gain of Rs287mn (vs. Rs41mn in 4QFY17) and 14.8% QoQ rise in core fee. On the other hand, fresh slippages increased sequentially to Rs887mn vs. Rs742mn in 4QFY17 led by higher slippages in LAP, AIB and gold loan portfolio. As a result, provisioning expenses rose by 72.9% YoY and 4.6% QoQ to Rs355mn. The Bank s net profit grew by 38.7% YoY and 23.4% QoQ to Rs652mn owing to strong growth in operating revenue, which oset higher provisioning and operating expenses. We reiterate our recommendation on the stock with a revised Target Price of Rs223 (from Rs27 earlier) based on 2.3x FY19E Adjusted book value. Management Commentary & Guidance The Bank opened 28 new branches during 1QFY18 and mulls opening another 1-2 branches by 2QFY18-end taking total branch count to 3-31. Subsequently, the Bank will expand branch network in such a manner that it does not impact overall cost to income ratio and profitability. Higher slippage is attributable to several ongoing disparaging events (GST roll-out, farm loan waiver by various states and negative impact of demonetisation in MFI portfolio). Looking forward, the Bank expect s improvement on slippages front. Loan book grew by 3% QoQ and 22% YoY led by CV and mortgage segment. The Bank expects 22-25% growth in loan book in FY18 and looks forward to double its loan book over the next 3 years. Other income is likely to grow by 15-17% YoY in FY18 led by strong growth in income from sale of Priority Sector Lending Certificate (PSLC) and third party product distribution. Outlook & Valuation The Management focuses on increasing loan book in low-ticket retail, SME & AIB segments and augmenting its footprint both on physical and digital front. Though this aggressive strategy of expanding footprints will marginally impact its return ratios in the near-term, it would bring forth substantial positive benefits in the long-term. Further, the Management focuses on increasing eiciency of existing network to improve cost to income ratio in the long-term, which will lead to sustained earnings growth. The bank has raised Rs3.8bn of fresh equity during 1QFY18 via QIP at 2.6x Mar 17 book value. As a result book value of the bank increased by 11% on sequential basis. Further, incremental capital will help the bank grow by 25-3% over the next 2 years. Post this capital rising, we have revised upward our book value and profit estimates for FY19 by 5% and 2% respectively. Accordingly, we have revised our Price Target to Rs223 (from Rs27 earlier) based on 2.3x FY19E Adjusted book value. Share price 1 mth 3 mth 12 mth Absolute performance (5.8) 14.5 98.4 Relative to Nifty (9.2) 6. 82.3 Shareholding Pattern Mar'16 Jun'17 Promoter 16.2 15. Mutual Funds 14.9 15.5 Insurance Companies 1.4 2.4 Foreign Portfolio Investors 23.6 22.5 Others 44. 44.5 Total 1. 1. 1 Year Stock Price Performance 25 2 15 1 5 Jul-16 Aug-16 Sep-16 Oct-16 Nov-16 Dec-16 Jan-17 Feb-17 Mar-17 Apr-17 May-17 Jun-17 Jul-17 Note: * CMP as on July 17, 217 Key Financials E FY19E NII 6,195 7,971 1,146 12,85 PPP 3,49 4,182 5,536 7,23 PAT 1,945 1,997 2,969 3,957 EPS (Rs) 6.8 7. 9.7 12.9 P/E (x) 29. 28.4 2.6 15.4 Adj. BV (Rs) 59.5 66. 84. 96.8 P/Adj. BV (x) 3.3 3. 2.4 2.1 Gross NPA 1.5 1.6 1.6 1.4 Net NPA.8.8.9.8 Avg. ROA 1.1.9 1.1 1.2 Avg. ROE 1.9 9.1 11. 12.8 Research Analyst : Asutosh Kumar Mishra Contact : (22) 3321323 Email : asutosh.mishra@relianceada.com 1

Upside/ (Downside) 12 Risks to the View Any major deterioration in macroeconomic environment may impact the Bank s growth plan as well as assets quality, which will in turn impact its financial performance. Any significant material change in new business strategy. Exhibit 1: Income Statement Analysis 1Q FY18 1Q FY17 % yoy / bps 4Q FY17 % qoq / bps FY17 FY16 % yoy / bps Interest on Advance 4,56 3,851 17. 4,318 4.3 16,48 13,541 21.7 YoA - Calculated 11.2 11.7 (5) 11.4 (13) 11.5 11.6 (11) Income on Investment 1,53 776 35.7 1,11 (4.3) 3,935 3,78 27.9 Interest on Balances 41 17 138.2 11 261.4 58 38 53.4 Others Interests 6 62 (2.9) 6 (.3) 289 328 (11.9) Interest Earned 5,66 4,76 2.3 5,491 3.1 2,761 16,985 22.2 Interest Expended 3,329 2,936 13.4 3,288 1.2 12,791 1,79 18.5 CoF - Calculated 5.8 6.4 (64) 5.8 (5) 6.3 6.5 (2) Net Interest Income 2,332 1,77 31.7 2,23 5.9 7,971 6,195 28.7 NIM - Calculated 4.2 4. 25 4. 23 4. 3.8 18 NIM - Reported 4.2 4.1 18 4. 19 4. 3.9 1 NII as % of Oper. Income 73.1 74.6 (154) 77.6 (449) 76.2 73.8 241 Core Fee Income 519 379 36.9 452 14.8 1,657 1,45 17.9 Fee Inc. as % of OI 16.3 16. 29 15.9 35 15.8 16.7 (5) Non Core Fee Income 339 222 52.3 184 84.1 837 8 4.7 Non core fee Inc. as % of OI 1.6 9.4 124 6.5 414 8. 9.5 (16) Total Other Income 858 61 42.6 636 34.9 2,495 2,25 13.2 Other Inc. as % of OI 26.9 25.4 154 22.4 449 23.8 26.2 (241) Operating Income (OI) 3,189 2,372 34.5 2,839 12.4 1,465 8,4 24.6 Core Operating Income 2,851 2,149 32.6 2,655 7.4 9,628 7,6 26.7 Employees Expenses 95 727 24.5 815 11. 3,8 2,451 25.7 Employees Expn. as % of OI 28.4 3.6 (228) 28.7 (35) 29.4 29.2 25 Other Operating Expenses 92 718 28.3 87 5.8 3,23 2,458 3.3 Other Opert Exp. as % of OI 28.9 3.3 (139) 3.6 (179) 3.6 29.3 134 Total Operating Expenses 1,825 1,444 26.4 1,685 8.3 6,283 4,99 28. Cost to income Ratio 57.2 6.9 (367) 59.4 (214) 6. 58.4 159 Operating Profit (OP) 1,364 927 47.1 1,153 18.3 4,182 3,49 19.8 Provisions and Conting. 355 25 72.9 339 4.6 1,115 879 26.8 Pro Burden as % of OP 26. 22.1 388 29.4 (339) 26.7 25.2 147 Profit Before Tax 1,9 722 39.8 814 24. 3,67 2,611 17.5 Tax Expenses 357 252 41.8 286 25. 1,7 666 6.7 Eective Tax Rate 35.4 34.9 51 35.1 3 34.9 25.5 94 Net Profit 652 47 38.7 529 23.4 1,997 1,945 2.6 EPS 2.2 1.7 31.5 1.9 17.3 7. 6.9 2.2 2

Upside/ (Downside) 12 Exhibit 2: NIMs improved by 19bps YoY led by favourable change in loan-mix and improvement in CASA ratio Exhibit 3: Healthy growth in higher-yielding loan book and improvement in NIMs led to strong growth in NII 4.3 4.2 4.1 4. 3.9 3.8 3.6 3.5 3.8 3.8 4. 3.9 4.1 4. 4. 4. 4.2 2,5 2, 1,5 1, 5 3.5 3.6 3.9 3.9 3.8 3.6 3.5 3.4 3.3 3.2 NII (LHS) NII as % of Avg. Assets Exhibit 4: Higher income from treasury operations and robust growth in core fee income aided the Bank s other income growth Exhibit 5: C/I ratio improved to 57.2% owing to healthy growth in operating income and rationalisation of branch opening expenses 1, 9 8 7 6 5 4 3 2 1 31. 24.5 22.7 26.7 25.4 24.5 23.4 22.4 26.9 35. 3. 25. 2. 15. 1. 5.. 2, 1,8 1,6 1,4 1,2 1, 8 6 4 2 55.9 6.7 59.4 57.8 6.9 6. 6.1 59.4 57.2 62 61 6 59 58 57 56 55 54 53 Other Income OI as % of Operating Income Operating Expenses C/I Ratio Exhibit 6: Despite relatively higher slippages, overall provisioning increased as focus remained on improving PCR Exhibit 7: PAT growth remained robust led by strong growth in NII and other income, which was partially oset by higher opex and provisioning expenses 4 35 3 25 2 15 1 5 2.1 27.7 24.9 28.1 22.1 26.2 27.9 29.4 26. 35 3 25 2 15 1 5 8 7 6 5 4 3 2 1 5. (1.1) (3.1) 1.5.3 31.3 24.5 (24.) 38.7 5. 4. 3. 2. 1.. (1.) (2.) (3.) PAT (LHS) Growth YoY (RHS) 3

Upside/ (Downside) 12 Exhibit 8: Balance Sheet Analysis (Rs bn) 4Q FY16 1Q FY17 2Q FY17 3Q FY17 4Q FY17 1Q FY18 QoQ% / bps YoY % / bps Net Worth 17.9 18.4 18.9 21.5 22. 26.2 19.1 42.6 Deposit 149 157 177 188 193 192 (.7) 22.2 Savings Deposits 23 24 26 32 32 35 9.7 44.3 Current Deposits 12 12 13 16 15 17 9.7 37.9 CASA Deposit 35 36 39 49 47 51 9.7 42.1 Term Deposit 114 121 138 14 146 14 (4.) 16.2 Investments 43 44 55 61 58 56 (4.) 27.4 Advances 129 133 144 146 158 163 2.8 22. Total Business 322 334 376 395 49 41.2 22.8 Avg Int. Earning Assets 171 175 192 212 218 22 1.1 26.1 Risk Weighted Assets 134 144 16 162 173 179 24.1 CAR 14.1 13.2 11.9 13.3 13.8 15.3 149 21 Tier I Capital 12.8 11.9 1.8 11.4 11.9 13.4 157 152 Exhibit 9: Loan book growth was led by commercial vehicle and mortgage segment Exhibit 1: Incremental growth in deposits slowed down as the Bank allowed maturity of high cost term deposits (Rs bn) (Rs bn) 14 1.1 12. 25 12.8 14. 12 1 7.2 8.2 8.5 1. 8. 2 12. 1. 8 6 4 2 (2) (.4) 5. 3.2 1. 2.8 6. 4. 2.. -2. 15 1 5 (5) 5.2 2.2 3.9 6. 5. 6.5 2.4 (.7) 8. 6. 4. 2.. (2.) Incremental loan disbursement (LHS) Adv. Gr. qoq Incremental Deposit Mobilization (LHS) Deposit Gr. qoq (RHS) Exhibit 11: Loan Book Analysis 4Q FY16 1Q FY17 2Q FY17 3Q FY17 4Q FY17 1Q FY18 QoQ% YoY % Mortgages 55,562 57,349 63,519 64,171 68,16 71,569 5.2 24.8 Commercial Vehicle 5,169 5,335 5,774 5,834 6,327 8,133 28.5 52.5 SME + Micro SME 15,56 14,671 15,88 16,43 18,981 17,892 (5.7) 22. Agri & Inclusive Banking 21,966 22,673 24,542 24,793 28,472 27,652 (2.9) 22. Corporate Banking 19,382 2,5 23,98 23,335 25,38 24,399 (3.6) 22. Other 11,629 13,337 11,549 11,668 11,72 13,13 17.5 (2.4) 4

Upside/ (Downside) 12 Exhibit 12: Loan Book Analysis (% Break Up) 4Q FY16 1Q FY17 2Q FY17 3Q FY17 4Q FY17 1Q FY18 QoQ bps YoY bps Mortgages 43. 43. 44. 47.8 46.2 47.8 159 483 Commercial Vehicle 4. 4. 4. 4.3 4.3 5.4 113 143 SME + Micro SME 12. 11. 11. 11. 12. 11. (1) - Agri & Inclusive Banking 17. 17. 17. 17. 18. 17. (1) - Corporate Banking 15. 15. 16. 16. 16. 15. (1) - Other 9. 1. 8. 8. 7. 8. 1 (2) Exhibit 13: CASA ratio improved by 27bps due to strong growth in saving deposits along with continued stickiness of deposits from demonetisation period Exhibit 14: Better ALM helped the bank to improve C/D ratio to 84%, which in turn led to better performance on NII front (Rs bn) 6 5 4 3 23. 24. 22.8 23. 23. 22. 25.9 24.3 27. 3. 25. 2. 15. 88 86 84 82 8 78 78.6 82.5 83.3 86.6 85.1 81.6 77.4 82. 84.9 2 1 1. 5. 76 74 72. C/D Ratio Exhibit 15: The Bank has raised Rs3.8bn in equities, which is expected to support its growth in coming 2 years Exhibit 16: RWA growth remained higher than loan growth, which led to relatively higher capital consumption (Rs bn) 18 16 14 12 1 8 6 4 2 14.3 13.9 13. 14.1 13.2 11.9 13.3 13.8 15.3 13.6 13.3 12.3 12.8 11.9 1.8 11.4 11.9 13.4 18. 16. 14. 12. 1. 8. 6. 4. 2.. 4.9 4.6 4.8 1.3 7.6 11. 1.1 6.5 12. 1. 8. 6. 4. 2.. Total CAR Tier I Incremental RWA (LHS) RWA Gr. qoq 5

Upside/ (Downside) 12 Exhibit 17: Asset Quality Analysis 4Q FY16 1Q FY17 2Q FY17 3Q FY17 4Q FY17 1Q FY18 QoQ% / bps YoY % / bps Gross Non Performing Assets 1,974 2,313 2,554 2,279 2,542 2,853 12.2 23.4 Fresh Slippages 59 579 5 793 742 887 19.5 53.2 Net Non Performing Assets 975 1,157 1,29 1,8 1,244 1,491 19.9 28.9 GNP Ratio 1.5 1.7 1.8 1.6 1.6 1.7 15 2 NNP Ratio.8.9.8.7.8.9 13 5 NPA Coverage Ratio 5.62 49.97 52.65 52.6 51.6 47.73 (333) (224) Restructured Gross Loans 32 29 29 3 36 32 (11.1) 1.3 Restructured Loan as % of Adv..2.2.2.2.2.2 (3) (2) Exhibit 18: Slippages increased sequentially owing to higher slippages from mortgage and AIB segment Exhibit 19: Incremental gross NPA formation increased due to lower upgrades and recovery along with higher slippages 3. 2.5 2. 1.5 1..5. 2.2 2.4 2. 1.7 1.8 1.5 2.2 2. 2.2 4 3 2 1 (1) (2) (3) (4) (5) 1.9 8.7 4.7 (16.) 17.2 1.4 (1.8) 11.5 12.2 25. 2. 15. 1. 5.. (5.) (1.) (15.) (2.) Incremental Gross NPA (LHS) Gross NPA Gr. qoq (RHS) Exhibit 2: PCR remained in comfort zone with specific PCR at 47.7% and PCR (including technical write-o) came in at 71.8% 55 5 45 4 35 3 38.5 42. 44.2 5.6 5. 52.7 52.6 51.1 47.7 Exhibit 21: Net NPA ratio remained well within the Management s comfort level 1,6 1,4 1,2 1, 8 6 4 2 1.2 1.2 1.1.8.9 Net NPA (LHS).8.7 Net NPA Ratio (RHS).8.9 1.4 1.2 1..8.6.4.2. 6

Upside/ (Downside) 12 Profit & Loss Statement Y/E March E FY19E Interest Earned 16,985 2,761 25,618 31,732 Interest Expenditure 1,79 12,791 15,472 18,882 Net Interest Income 6,195 7,971 1,146 12,85 Fee Income 1,45 1,657 1,957 2,569 Non Fee Income 8 837 1,133 1,264 Other Income 2,25 2,495 3,9 3,834 Net Operating Income 8,4 1,465 13,236 16,684 Core Operating Income 7,6 9,628 12,13 15,419 Employee Expenses 2,451 3,8 3,696 4,436 Other Expenses 2,458 3,23 4,4 5,45 Operating Expenses 4,99 6,283 7,7 9,48 Operating Profit 3,49 4,182 5,536 7,23 Provisions and Contingencies 879 1,115 1,3 1,163 Profit Before Tax 2,611 3,67 4,533 6,41 Taxes 666 1,7 1,564 2,84 Profit After Tax 1,945 1,997 2,969 3,957 Balance Sheet Y/E March E FY19E Capital & Liabilities Capital 2,844 2,854 3,75 3,75 Reserves Total 15,62 19,179 23,913 27,873 Net Worth 17,96 22,33 26,989 3,948 Deposits 149,26 192,892 239,186 31,375 Current deposits 11,771 15,347 19,972 25,617 Saving deposits 23,127 31,545 4,422 52,741 Term Deposits 114,361 146, 178,792 223,17 Borrowings 11,479 12,758 13,78 15,358 Other Liabilities & Provisions 12,525 12,765 14,878 16,76 Total Liabilities 191,185 24,464 294,777 364,43 Assets Cash & Cash Equivalents 8,916 11,925 13,17 15,139 Investments 43,333 58,179 7,741 85,923 Advances 129,214 158,176 197,72 249,128 Fixed Assets 2,48 4,886 5,582 6,244 Other Assets 7,242 7,298 7,626 7,969 Total Assets 191,185 24,464 294,777 364,43 7

Upside/ (Downside) 12 Per Share Data and Valuation Y/E March FY16 FY17E FY18E FY19E No. of Shares (Mn) 284.4 285.4 37.5 37.5 Earnings Per Share (Rs.) 6.8 7. 9.7 12.9 Book Value / Share (Rs.) 61.2 68.2 85.2 98. ABV/Share (Rs.) 59.5 66. 84. 96.8 Dividend Per Share (Rs.) - -.1.1 Price/ Earnings (X) 29. 28.4 2.6 15.4 Price/ BV (X) 3.2 2.9 2.3 2. Price/Adjusted BV (X) 3.3 3. 2.4 2.1 Key Assumptions Y/E March E FY19E Loan Growth 23.5 22.4 25. 26. Deposit Growth 18.4 29.2 24. 26. RWA Growth 24.2 22. 23. 28.2 Slippages Ratio 2.2 2. 1.8 1.6 Cost of Fund 6.5 6.3 6.1 6. Yield on Fund 1.6 1.5 1.4 1.4 NIM 3.8 4. 4.1 4.2 Other Income Growth 33.1 13.1 23.9 24.1 Cost to Income Ratio 58.4 6. 58.2 56.8 Average Credit Cost.8.9.6.6 Eective Tax Rate 25.5 34.9 34.5 34.5 Growth Rate Y/E March E FY19E Net interest Income 21.9 28.7 27.3 26.7 Other Income 33. 13.2 23.9 24.1 Operating Profit 25.8 19.8 32.4 3.1 Provisions Expense 26.6 26.8 (1.1) 16. PAT 1.7 2.6 48.7 33.3 Risk Weighted Assets 24.2 22. 23. 28.2 Yields / Margins Y/E March E FY19E Cost of Funds (CoF) 6.5 6.3 6.1 6. Yield on Advance 11.6 11.5 11.4 11.4 Yield on funds 1.6 1.5 1.4 1.4 Net Interest Margin (NIM) 3.8 4. 4.1 4.2 8

Upside/ (Downside) 12 Balance Sheet Ratio Y/E March E FY19E Credit / Deposit Ratio 86.6 82. 82.7 82.7 Incremental C/D Ratio 16. 66.4 85.4 82.7 Investment-Deposit Ratio 29. 3.2 29.6 28.5 CASA Ratio 23.4 24.3 25.3 26. Asset Quality Y/E March E FY19E Gross NPA/Gross Advances 1.5 1.6 1.6 1.4 Net NPA/Net Advances.8.8.9.8 Provisioning Burden as % of PPP 25.2 26.7 18.1 16.1 Provisioning Coverage Ratio 5.6 51.1 41. 4.5 Slippage ratio 2.2 2. 1.8 1.6 Provis. Exp. to Avg. Advance.8.8.6.5 RoA Tree Analysis Y/E March E FY19E NII / Avg. Assets 3.5 3.8 3.9 Core Fee / Avg. Assets.8.8.7.8 Core Rev. / Avg. Assets 1.3 1.2 1.2 1.2 Ope. Exp. / Avg. Assets 2.8 2.9 2.9 2.9 Cost to Income 58.4 6. 58.2 56.8 Emp. cost / Avg. Assets 1.4 1.4 1.4 1.3 Oprt. Exp. / Avg. Assets 2.8 2.9 2.9 2.9 Core OP/ Avg. Assets 1.5 1.5 1.6 1.8 Trading & Ot/ Avg. Assets.5.4.4.4 OP/ Avg. Assets 2. 1.9 2.1 2.2 Provisions / Avg. Assets.5.5.4.4 NPA prov. / Avg. Assets.3.3.2.2 PBT / Avg. Assets 1.5 1.4 1.7 1.8 Tax / Avg. Assets.4.5.6.6 Eective Tax Rate 25.5 34.9 34.5 34.5 RoA 1.1.9 1.1 1.2 Leverage (x) 1.7 1.9 1.9 11.8 RoE 1.9 9.1 11. 12.8 Capital Adequacy Ratio Y/E March E FY18E Total CAR 14.1 13.8 1 12.4 Tier 1 12.8 11.9 12.1 1.9 9

Upside/ (Downside) 12 Rating Guides Rating Expected absolute returns over 12 months >1% HOLD -5% to 1% REDUCE >-5% Reliance Securities Limited (RSL), the broking arm of Reliance Capital is one of the India s leading retail broking houses. Reliance Capital is amongst India s leading and most valuable financial services companies in the private sector. Reliance Capital has interests in asset management and mutual funds, life and general insurance, commercial finance, equities and commodities broking, wealth management services, distribution of financial products, private equity, asset reconstruction, proprietary investments and other activities in financial services. The list of associates of RSL is available on the website www.reliancecapital.co.in. RSL is registered as a Research Analyst under SEBI (Research Analyst) Regulations, 214 General Disclaimers: This Research Report (hereinafter called Report ) is prepared and distributed by RSL for information purposes only. The recommendations, if any, made herein are expression of views and/or opinions and should not be deemed or construed to be neither advice for the purpose of purchase or sale of any security, derivatives or any other security through RSL nor any solicitation or oering of any investment /trading opportunity on behalf of the issuer(s) of the respective security(ies) referred to herein. These information / opinions / views are not meant to serve as a professional investment guide for the readers. No action is solicited based upon the information provided herein. Recipients of this Report should rely on information/data arising out of their own investigations. Readers are advised to seek independent professional advice and arrive at an informed trading/investment decision before executing any trades or making any investments. This Report has been prepared on the basis of publicly available information, internally developed data and other sources believed by RSL to be reliable. RSL or its directors, employees, ailiates or representatives do not assume any responsibility for, or warrant the accuracy, completeness, adequacy and reliability of such information / opinions / views. While due care has been taken to ensure that the disclosures and opinions given are fair and reasonable, none of the directors, employees, ailiates or representatives of RSL shall be liable for any direct, indirect, special, incidental, consequential, punitive or exemplary damages, including lost profits arising in any way whatsoever from the information / opinions / views contained in this Report. Risks: Trading and investment in securities are subject to market risks. There are no assurances or guarantees that the objectives of any of trading / investment in securities will be achieved. The trades/ investments referred to herein may not be suitable to all categories of traders/investors. The names of securities mentioned herein do not in any manner indicate their prospects or returns. The value of securities referred to herein may be adversely aected by the performance or otherwise of the respective issuer companies, changes in the market conditions, micro and macro factors and forces aecting capital markets like interest rate risk, credit risk, liquidity risk and reinvestment risk. Derivative products may also be aected by various risks including but not limited to counter party risk, market risk, valuation risk, liquidity risk and other risks. Besides the price of the underlying asset, volatility, tenor and interest rates may aect the pricing of derivatives. Disclaimers in respect of jurisdiction: The possession, circulation and/or distribution of this Report may be restricted or regulated in certain jurisdictions by appropriate laws. No action has been or will be taken by RSL in any jurisdiction (other than India), where any action for such purpose(s) is required. Accordingly, this Report shall not be possessed, circulated and/ or distributed in any such country or jurisdiction unless such action is in compliance with all applicable laws and regulations of such country or jurisdiction. RSL requires such recipient to inform himself about and to observe any restrictions at his own expense, without any liability to RSL. Any dispute arising out of this Report shall be subject to the exclusive jurisdiction of the Courts in India. Disclosure of Interest: The research analysts who have prepared this Report hereby certify that the views /opinions expressed in this Report are their personal independent views/opinions in respect of the securities and their respective issuers. None of RSL, research analysts, or their relatives had any known direct /indirect material conflict of interest including any long/short position(s) in any specific security on which views/opinions have been made in this Report, during its preparation. RSL s Associates may have other potential/material conflict of interest with respect to any recommendation and related information and opinions at the time of publication of research report. RSL, its Associates, the research analysts, or their relatives might have financial interest in the issuer company(ies) of the said securities. RSL or its Associates may have received a compensation from the said issuer company(ies) in last 12 months for the brokerage or non brokerage services.rsl, its Associates, the research analysts or their relatives have not received any compensation or other benefits directly or indirectly from the said issuer company(ies) or any third party in last 12 months in any respect whatsoever for preparation of this report. The research analysts has served as an oicer, director or employee of the said issuer company(ies)?: No RSL, its Associates, the research analysts or their relatives holds ownership of 1% or more, in respect of the said issuer company(ies).?: No Copyright: The copyright in this Report belongs exclusively to RSL. This Report shall only be read by those persons to whom it has been delivered. No reprinting, reproduction, copying, distribution of this Report in any manner whatsoever, in whole or in part, is permitted without the prior express written consent of RSL. RSL s activities were neither suspended nor have defaulted with any stock exchange with whom RSL is registered. Further, there does not exist any material adverse order/judgments/ strictures assessed by any regulatory, government or public authority or agency or any law enforcing agency in last three years. Further, there does not exist any material enquiry of whatsoever nature instituted or pending against RSL as on the date of this Report. Important These disclaimers, risks and other disclosures must be read in conjunction with the information / opinions / views of which they form part of. RSL CIN: U6599MH25PLC15452. SEBI registration no. ( Stock Brokers: NSE - INB / INF / INE 231234833; BSE - INB / INF / INE 11234839, Depository Participants: CDSL IN-DP-257-216 IN-DP-NSDL-363-213, Research Analyst: INH2384); AMFI ARN No.29889. 1